U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07145593) titled 'Gamma tACS in Attention-Deficit/Hyperactivity Disorder' on July 30.
Brief Summary: Attention-Deficit/Hyperactivity Disorder (ADHD) is a common neurodevelopmental disorder characterized by symptoms of inattention, impulsivity, and hyperactivity. These symptoms are often associated with impairments in executive functions and working memory, which are essential for goal-directed behavior and cognitive control. Deficits in these domains can significantly hinder individuals' academic, social, and daily functioning. Gamma oscillations (30-80 Hz) play a crucial role in cognitive integration, attention, and memory processes, and are thought...